The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Melphalan/hepatic delivery system versus best available care in patients with unresectable metastatic uveal melanoma: Randomized FOCUS trial results.
 
Jonathan S. Zager
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Honoraria - Castle Biosciences; Delcath Systems; Merck; Merit Medical Systems; Sun Pharma
Consulting or Advisory Role - Castle Biosciences; Delcath Systems; Philogen
Speakers' Bureau - Merit Medical Systems; Pfizer; Sun Pharma
Research Funding - Castle Biosciences (Inst); Delcath Systems (Inst); NeraCare GmbH (Inst); Philogen (Inst); Provectus (Inst)
Patents, Royalties, Other Intellectual Property - US Patent # 11,779,698; US Patent 10,583,246
Expert Testimony - Bubalo Law; McGowan, Hood, Felder & Phillips, LLC
Travel, Accommodations, Expenses - Merck
 
Marlana M. Orloff
Employment - GlaxoSmithKline (I)
Consulting or Advisory Role - Delcath Systems; IDEAYA Biosciences; Immunocore; Replimune; TriSalus Life Sciences
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Delcath Systems (Inst); IDEAYA Biosciences (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Linnaeus Therapeutics (Inst); TriSalus Life Sciences (Inst)
 
Pier Francesco Ferrucci
Expert Testimony - Delcath Systems
 
Junsung Choi
Consulting or Advisory Role - Delcath Systems
 
David J. Eschelman
Consulting or Advisory Role - Delcath Systems
 
Evan Scott Glazer
Research Funding - Delcath Systems (Inst)
Patents, Royalties, Other Intellectual Property - Anviron stock options
 
Aslam Ejaz
Consulting or Advisory Role - Natera
 
Erika Richtig
Stock and Other Ownership Interests - Roche Pharma AG
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Delcath Systems; Immunocore; Merck; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Novartis; Pierre Fabre
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); CureVac (Inst); CureVac (Inst); Delcath Systems (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pierre Fabre (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
 
Sebastian Ochsenreither
Honoraria - AstraZeneca; BMS; immunocore; Janssen Oncology; Merck Serono; MSD
Consulting or Advisory Role - immunocore; Janssen-Cilag; MSD; Pfizer
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - Cyclin A1 as T-cell target
Travel, Accommodations, Expenses - Janssen Oncology; Merck Serono; Pfizer
 
Sunil A. Reddy
Consulting or Advisory Role - EMD Serono
(OPTIONAL) Uncompensated Relationships - IDEAYA Biosciences; IDEAYA Biosciences
 
Michael C. Lowe
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Merck
Research Funding - Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Delcath Systems (Inst); Regeneron (Inst); Skyline Diagnostics (Inst); Vaccinex (Inst)
 
Georgia Beasley
Honoraria - National Comprehensive Cancer Network
Consulting or Advisory Role - Bristol Myers Squibb; Cardinal Health; Regeneron
Research Funding - Checkmate Pharmaceuticals (Inst); Delcath Systems (Inst); Istari Oncology (Inst); Oncosec (Inst); Replimune (Inst); Skyline Diagnostics (Inst)
 
Anja Heike Gesierich
Honoraria - Almirall Hermal GmbH; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Pierre Fabre
Travel, Accommodations, Expenses - Novartis; Pierre Fabre; Sanofi Aventis GmbH
 
Martin Gschnell
Honoraria - Almirall; Bristol-Myers Squibb; Delcath Systems; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Sanofi
Travel, Accommodations, Expenses - Almirall
 
Reinhard Dummer
Honoraria - Alligator Bioscience; Amgen; Bristol-Myers Squibb; Catalym; MaxiVax ; MSD; Novartis; Pfizer; Pierre Fabre; Regeneron; Roche; Sanofi; Second Genome; Sun Pharma; T3 Pharmaceuticals; Takeda; touchIME
Consulting or Advisory Role - Alligator Bioscience; Amgen; Bristol-Myers Squibb; Catalym; MaxiVax ; MSD; Novartis; Pfizer; Pierre Fabre; Regeneron; Roche; Sanofi; Sun Pharma; T3 Pharmaceuticals; Takeda; touchIME
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Ana Maria Arance
Consulting or Advisory Role - BioNTech SE; BMS; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - BMS; MSD; Novartis; Pierre Fabre; Roche
Research Funding - BioNTech SE (Inst); BMS (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; MSD
 
Stephen William Fenwick
Honoraria - Merck Serono
Speakers' Bureau - Merck Serono
Travel, Accommodations, Expenses - Merck Serono
 
Johnny John
Employment - Delcath Systems
Stock and Other Ownership Interests - Delcath Systems
 
Matthew Wheater
Honoraria - Delcath Systems; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; bristol-Myers Squibb; Delcath systems; Ipsen
Research Funding - AVEO (Inst); Bristol-Myers Squibb/Medarex (Inst); Delcath Systems (Inst); GlaxoSmithKline/Novartis (Inst); MSD (Inst); MSD (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; MSD; Novartis
 
Christian H.H Ottensmeier
Stock and Other Ownership Interests - NEUVOGEN
Honoraria - Delcath Systems; Transgene
Consulting or Advisory Role - Bristol-Myers Squibb; Delcath Systems; Merck Sharp & Dohme; NEUVOGEN
Speakers' Bureau - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme; Roche
Research Funding - BioNTech (Inst); Bristol-Myers Squibb (Inst); Delcath Systems (Inst); Merck Sharp & Dohme (Inst); PsiOxus Therapeutics (Inst); Scancell (Inst); Touchlight Genetics (Inst); Verastem (Inst)
Patents, Royalties, Other Intellectual Property - patents on modulation of T cell function
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Delcath Systems
Other Relationship - Transgene